Skip to main content
SpringerLink
Log in

Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

The phenotypic distribution of T-lymphocyte subsets in peripheral blood from multiple myeloma (MM) patients shows a reduced proportion of CD4+ cells and a normal proportion of CD8+ cells. The decrease in CD4+ cells could be due to a random process, with all types of CD4+ cells being equally affected, or it could reflect a nonrandom process with selected subsets preferentially reduced. In order to distinguish between these possibilities, double immunofluorescence analysis was performed on blood samples from patients with MM, patients with monoclonal gammopathy of unknown significance (MGUS), and age-matched normal donors, using monoclonal anti-CD4 or anti-CD8 paired with antibodies to the common leukocyte marker Lp220 (CD45R) or 4B4 (CDw29). Normal peripheral blood lymphocytes (PBL) include two phenotypically and functionally distinct CD4+-cell subsets, identified as CD4+ Lp220+ 4B4-and CD4+ Lp220- 4B4+, whereas the majority of CD8+ cells expresses Lp220 (70–85%). MM patients had a highly significant selective reduction of the CD4+ Lp220+ subset compared with normal controls (P<0.001). Although the percentage of CD4+ Lp220- cells was also reduced in some MM patients relative to normal donors, most of MM patients had an elevated Lp220-/Lp220+ ratio of CD4+ cells (P<0.001). The proportion of the two CD8+ subsets was also markedly abnormal. In the set of patients studied the abnormalities within the CD4+ and CD8+ lymphocytes were exclusive to patients with MM since patients with MGUS had normal proportion of CD4+ and CD8+ subsets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Churg J, Gordon AJ: Multiple myeloma. Am J Clin Pathol 20:934–939, 1950

    Google Scholar 

  2. Fritz E, Ludwig H, Kundi M: Prognostic relevance of cellular morphology in multiple myeloma. Blood 63:1072–1079, 1984

    Google Scholar 

  3. Pilarski LM, Mant MJ, Ruether BA: Review: Analysis of immunodeficiency in multiple myeloma: Observations and hypothesis. J Clin Lab Anal 1:214–228, 1987

    Google Scholar 

  4. Ullrich S, Zolla-Pazner S: Immunoregulatory circuits in myeloma. Clin Haematol 11:87–111, 1982

    Google Scholar 

  5. Border S, Megson M: The interrelationship between cancer and immunodeficiency.In Cancer in the Young, AS Levine (ed). Masson, New York, 1982, p 29–52

    Google Scholar 

  6. Perri RT, Oken MM, Kay NE: Enhanced T cell suppression is Directed toward sensitive circulating B cells in multiple myeloma. J Lab Clin Med 99:512–519, 1982

    Google Scholar 

  7. Pilarski LM, Mant MJ, Ruether BA, Belch A: Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients. J Clin Invest 74:1301–1306, 1984

    Google Scholar 

  8. Pilarski LM, Mant MJ, Ruether BA: Pre-B cells in peripheral blood of multiple myeloma patients. Blood 66:416–422, 1985

    Google Scholar 

  9. Pilarski LM, Andrews EJ, Mant MJ, Ruether BA: Humoral immune deficiency in multiple myeloma patients due to compromised B cell function. J Clin Immunol 6:491–501, 1986

    Google Scholar 

  10. Pilarski LM, Piotrowska-krezolak M, Gibney DJ, Winger L, Winger C, Mant MJ, Ruether BA: Specificity repertoire of lymphocytes from multiple myeloma patients. I. High frequency of B cells specific for idiotypic and F(ab′)2 region determinants on immunoglobulin. J Clin Immunol 5:275–284, 1985

    Google Scholar 

  11. Pilarski LM, Mant MJ, Ruether BA, Carayanniotis G, Otto D, Krowka JF: Abnormal clonogenic potential of T cells from multiple myeloma patients. Blood 66:1266–1271, 1985

    Google Scholar 

  12. Lauria F, Foa R, Cavo M, Gobbi M, Raspodori D, Giubellino MC, Tazzari PL, Tura S: Membrane phenotype and functional behavior of T lymphocytes in multiple myeloma: Correlation with clinical stages of the disease. Clin Exp Immunol 56:653–658, 1984

    Google Scholar 

  13. Herrmann F, Lochner A, Jauer B, Sieber G, Ruhl H: Lymphocyte subsets in the peripheral blood of patients with multiple myeloma and benign monoclonal gammopathy. Klin Wochenschrift 61:819–821, 1983

    Google Scholar 

  14. Platsoucas CD, Hansen HJ, Redman JR, Berenson S, Burton JL III, Bayard DC: T-cell imbalances in patients with multiple myeloma: An analysis by monoclonal antibodies. J Clin Immunol 3:277–284, 1983

    Google Scholar 

  15. Mellstedt H, Holm G, Pettersson D, Bjorkholm M, Johansson B, Lindemalm C, Peest D, Ahre A: T cells in monoclonal gammopathies. Scand J Haematol 29:57–64, 1982

    Google Scholar 

  16. Pezzutto A, Semenzato G, Agostini C, Raimondi R, Gasparotto G: Subpopulations of T-lymphocytes in multiple myeloma. Scand J Immunol 26:333–338, 1981

    Google Scholar 

  17. Mills KHG, Cawley JC: Abnormal monoclonal antibody-defined helper/suppressor T cell subpopulations in multiple myeloma: Relationship to treatment and clinical stage. Br J Haematol 53:271–275, 1983

    Google Scholar 

  18. Ledbetter JA, Rose L, M, Spooner CE, Beatty PG, Martin PJ, Clark EA: Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression. J Immunol 135:1819–1825, 1985

    Google Scholar 

  19. Morimoto C, Letvin NL, Distaso JA, Brown HM, Schlossman SF: The cellular basis for the induction of antigen-specific T8 suppressor cells. Eur J Immunol 16:198–204, 1986

    Google Scholar 

  20. Smith SH, Brown MH, Rowe D, Callard RE, Beverly PC: Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology 58:63–70, 1986

    Google Scholar 

  21. Morimoto C, Letvin N, Boyd AW, Hagan M, Brown HM, Kornacki MM, Schlossman SF: The isolation and characterization of the human helper inducer T cell subset. J Immunol 134:3762–3769, 1985

    Google Scholar 

  22. Morimoto C, Letvin NL, Rudd CE, Hagan M, Takeuchi T, Schlossman SF: The role of the 2H4 molecule in the generation of suppressor function in ConA-activated T cells. J Immunol 137:3247–3253, 1986

    Google Scholar 

  23. Durie BGM, Salmon SS: Staging, kinetics, and flow cytometry of multiple myeloma.In Neoplastic Diseases of the Blood, P Wiernik, G Canellos, R Kyle, C Schiffer (eds). New York, Churchill Livingston, 1985, Vol 2, pp 513

    Google Scholar 

  24. Kyle RA, Greipp PR: Monoclonal gammopathies of undetermined significance.In Neoplastic Diseases of the Blood, Vol. 2, PH Wiernik, GP Canellos, RA Kyle, CA Schiffer (eds). New York, Churchill Livingston, 1985, p 653

    Google Scholar 

  25. Ledbetter JA, Clark EA: Surface phenotype and function of human tonsillar germinal center and mantle zone B cell subsets. Hum Immunol 15:30–43, 1986

    Google Scholar 

  26. Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF: The isolation and characterization of the human suppressor inducer T cell subset. J Immunol 134:1508–1515, 1985

    Google Scholar 

  27. Ozer H, Han T, Henderson ES, Nussbaum A, Sheedy D: Immunoregulatory T cell function in multiple myeloma. J Clin Invest 67:779–789, 1981

    Google Scholar 

  28. Bergmann L, Mitrou PS, Weber KC, Kelker W: Imbalances of T-cell subsets in monoclonal gammopathies. Cancer Immunol Immunother 17:112–116, 1984

    Google Scholar 

  29. Serra HM, Ledbetter JA, Krowka JF, Pilarski LM: Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. J Immunol 140:1435–1441, 1988.

    Google Scholar 

  30. Pilarski LM, Andrews EJ, Serra HM, Ruether BA, Mant MJ: Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma (submitted for publication)

Download references

Author information

Authors and Affiliations

  1. Departments of Immunology and Medicine, University of Alberta, Edmonton, Alberta, Canada

    Horacio M. Serra, Michael J. Mant, Bernard A. Ruether & Linda M. Pilarski

  2. Department of Medicine, University of Calgary, Calgary, Alberta, Canada

    Horacio M. Serra, Michael J. Mant, Bernard A. Ruether & Linda M. Pilarski

  3. Oncogen, 98121, Seattle, Washington

    Jeffrey A. Ledbetter

Authors
  1. Horacio M. Serra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Mant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernard A. Ruether
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeffrey A. Ledbetter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Linda M. Pilarski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serra, H.M., Mant, M.J., Ruether, B.A. et al. Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients. J Clin Immunol 8, 259–265 (1988). https://doi.org/10.1007/BF00916554

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00916554

Key words

Search

Navigation